Abstract:Objective To compare the efficacies of early intensive and moderate insulin therapy on the prognosis of patients with severe acute pancreatitis (SAP).Methods The clinical data of 78 patients with SAP complicated by hyperglycemia who were admitted to the Second Hospital of Lanzhou University from January 2005 to December 2009 were retrospectively analyzed.All patients were divided into the intensive insulin therapy (IIT)group (31 patients) and moderate insulin therapy (MIT) group (47 patients).The target levels of blood glucose were 0.80-1.10 g/L(4.4-6.1 mmol/L) in the IIT group and 1.44-1.80 g/L(8.0-10.0 mmol/L) in the MIT group,respectively.The effects of the 2 therapies on the prognosis of the patients were compared.All data were analyzed by the t test or chi-square test.Results The daily intravenous insulin dosage,fasting glucose level and incidence of severe hypoglycemia were ( 35 ± 11 ) u,( 1.02 ± 0.13 ) g/L[ (5.7 ± 0.7 ) mmol/L] and 10％ (3/31 )in the IIT group,and ( 24 ± 15 ) u,( 1.58 ± 0.21 ) g/L[ ( 8.8 ± 1.2 ) mmol/L] and 2％ ( 1/47 ) in the MIT group.A significant difference was detected in the daily intravenous insulin dosage between the 2 groups( t =12.76,P ＜=0.05),but no significant difference was detected in the incidence of severe hypoglycemia between the 2 groups (x2 =0.91,P ＞ 0.05 ).The levels of albumin and prealbumin on the 14th day were ( 34 ± 6) g/L and (231 ± 31 ) mg/L in the IIT group,and (35 ± 5)g/L and (241 ± 29)mg/L in the MIT group,respectively,with no significant difference between the 2 groups( t =-1.94,-1.68,P ＞ 0.05).The incidences of abdominal infection,circulatory dysfunction,respiratory dysfunction and acquired kidney injury were 23％ (7/31),32％ (10/31),26％ (8/31)and 13％ (4/31) in the lIT group,and 26％ (12/47),36％ ( 17/47),30％ (14/47) and 23％ (11/47) in the MIT group,with no significant difference between the 2 groups(x2 =0.09,0.13,0.15,1.33,P ＞ 0.05).The scores of APPACHE Ⅱ on the 14th day were 9 ± 4 in the IIT group and 9 ± 3 in the MIT group,respectively,with no significant difference between the 2 groups ( t =- 0.60,P ＞ 0.05 ).There were 4 ( 13％ ) patients in the IIT group and 7( 15％ ) patients in the MIT group died of multi-organ dysfunction syndrome,including 2 patients in the IIT group and 6 patients in the MIT group complicated with sepsis.There was no significant difference in the mortality between the 2 groups ( x2 =0,P ＞ 0.05 ).Conclusions Compared with MIT,early IIT could not improve the prognosis of the patients with SAP.MIT is appropriate for SAP patients complicated with hyperglycemia.

[The Influence of Intensive Insulin Therapy on the Mortality of Critically Ill Patients in Intensive Care Unit: a Meta-Analysis].

Intensive Insulin Therapy for Septic Patients: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Intensive Insulin Therapy for Critically Ill Neurologic Patients: a Meta-Analysis.

Impact of Intensive Insulin Therapy on Surgical Critically Ill Patients

Impact of insulin therapy to control blood glucose on different levels on criticaly ill patients

Effect of intensive insulin therapy on critically ill patients

Intensive Versus Conventional Insulin Therapy in Stroke (a Meta-analysis)

Meta-analysis of Safety and Efficacy of 2 Insulin Therapy in Stress Hyperglycemia Patients

Intensive Insulin Therapy: Its Effect on the Prognosis of Critically Ill Patients

[Effect of Intensive Insulin Therapy on Prognosis in Patients With Acute Myocardial Infarction].

The effectiveness of intensive insulin therapy for preventing intensive care unit acquired weakness：a Meta-analysis

Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis

Intensive Insulin Therapy in Severe Acute Pancreatitis: a Meta-Analysis and Systematic Review.

Effects of Intensive Insulin Therapy on Immune Factors of Obstetrics Patients with Critical Illness

Intensive Versus Conventional Glucose Control In Critically Ill Patients: A Meta-Analysis Of Randomized Controlled Trials

Effects of early intensive and moderate insulin therapy on the prognosis of patients with severe acute pancreatitis

Application of intensive insulin therapy in critical illnesses

Intensive- Vs Less-Intensive-dose Continuous Renal Replacement Therapy for the Intensive Care Unit–related Acute Kidney Injury: A Meta-Analysis and Systematic Review

A Patient-Level Meta-Analysis of Intensive Glucose Control in Critically Ill Adults

Blood sugar control in the intensive care unit: time to relook